BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8468683)

  • 1. Epithelial transport of drugs in cell culture. VIII: Effects of sodium dodecyl sulfate on cell membrane and tight junction permeability in human intestinal epithelial (Caco-2) cells.
    Anderberg EK; Artursson P
    J Pharm Sci; 1993 Apr; 82(4):392-8. PubMed ID: 8468683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route.
    Anderberg EK; Lindmark T; Artursson P
    Pharm Res; 1993 Jun; 10(6):857-64. PubMed ID: 8321854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactants enhance the tight-junction permeability of food allergens in human intestinal epithelial Caco-2 cells.
    Mine Y; Zhang JW
    Int Arch Allergy Immunol; 2003 Feb; 130(2):135-42. PubMed ID: 12673067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial transport of drugs in cell culture. VII: Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells.
    Anderberg EK; Nyström C; Artursson P
    J Pharm Sci; 1992 Sep; 81(9):879-87. PubMed ID: 1432633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
    Liu DZ; LeCluyse EL; Thakker DR
    J Pharm Sci; 1999 Nov; 88(11):1161-8. PubMed ID: 10564065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin regulates the paracellular permeability of cultured intestinal epithelial cell monolayers.
    McRoberts JA; Aranda R; Riley N; Kang H
    J Clin Invest; 1990 Apr; 85(4):1127-34. PubMed ID: 2156894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paracellular drug transport across intestinal epithelia: influence of charge and induced water flux.
    Karlsson J; Ungell A; Gråsjö J; Artursson P
    Eur J Pharm Sci; 1999 Oct; 9(1):47-56. PubMed ID: 10493996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.
    Hurni MA; Noach AB; Blom-Roosemalen MC; de Boer AG; Nagelkerke JF; Breimer DD
    J Pharmacol Exp Ther; 1993 Nov; 267(2):942-50. PubMed ID: 7504101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line.
    Marano CW; Lewis SA; Garulacan LA; Soler AP; Mullin JM
    J Membr Biol; 1998 Feb; 161(3):263-74. PubMed ID: 9493132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
    Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
    J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells.
    Artursson P; Magnusson C
    J Pharm Sci; 1990 Jul; 79(7):595-600. PubMed ID: 2118955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic effects of pamidronate on monolayers of human intestinal epithelial (Caco-2) cells and its epithelial transport.
    Twiss IM; de Water R; den Hartigh J; Sparidans R; Ramp-Koopmanschap W; Brill H; Wijdeveld M; Vermeij P
    J Pharm Sci; 1994 May; 83(5):699-703. PubMed ID: 8071824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Starch microspheres induce pulsatile delivery of drugs and peptides across the epithelial barrier by reversible separation of the tight junctions.
    Björk E; Isaksson U; Edman P; Artursson P
    J Drug Target; 1995; 2(6):501-7. PubMed ID: 7773612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo analysis of the mechanism of absorption enhancement by palmitoylcarnitine.
    Hochman JH; Fix JA; LeCluyse EL
    J Pharmacol Exp Ther; 1994 May; 269(2):813-22. PubMed ID: 8182550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of tight junctions does not predict oral absorption of hydrophilic compounds: use of Caco-2 and Calu-3 cells.
    Kamath AV; Morrison RA; Mathias NR; Dando SA; Marino AM; Chong S
    Arch Pharm Res; 2007 Aug; 30(8):1002-7. PubMed ID: 17879754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective and superoxide-independent disruption of intestinal epithelial tight junctions during leukocyte transmigration.
    Nash S; Stafford J; Madara JL
    Lab Invest; 1988 Oct; 59(4):531-7. PubMed ID: 2845192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water pathways across a reconstituted epithelial barrier formed by Caco-2 cells: effects of medium hypertonicity.
    Parisi M; Pisam M; Calamita G; Gobin R; Toriano R; Bourguet J
    J Membr Biol; 1995 Feb; 143(3):237-45. PubMed ID: 7769609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of various absorption enhancers on tight junction in the human intestinal Caco-2 cell line.
    Yu Q; Wang Z; Li P; Yang Q
    Drug Dev Ind Pharm; 2013 Apr; 39(4):587-92. PubMed ID: 22656319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement.
    Ma TY; Tran D; Hoa N; Nguyen D; Merryfield M; Tarnawski A
    Microsc Res Tech; 2000 Oct; 51(2):156-68. PubMed ID: 11054866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic basis for unexpected bioavailability enhancement of polyelectrolyte complexes incorporating BCS class III drugs and carrageenans.
    Heinen C; Reuss S; Saaler-Reinhardt S; Langguth P
    Eur J Pharm Biopharm; 2013 Sep; 85(1):26-33. PubMed ID: 23958316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.